Answers are grounded in this paper and cite their sources.
Non-alcoholic fatty liver disease (NAFLD) comprises a spectrum of disorders which affect the liver, but were proven to have implications in many other organs and systems.It is now widely accepted that NAFLD has many comorbidities, mainly metabolic and cardio-vascular.Even if much comorbidity are well-explained, there are many other diseases associated with NAFLD in which the pathophysiological pathways are not completely understood.Research is conducted nowadays with the goal of completely elucidate the pathogenesis of NAFLD and its comorbidities, in order to eventually find a targeted cure for this "epidemic" liver disease.The purpose of this review is to present the non-cardiometabolic comorbidities of NAFLD, by using epidemiological and , physiopathological data, and to bring updated information on their treatment.
No takes yet. Share an insight, caveat, or question.
Milaciu et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: